Article info

Download PDFPDF
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
  1. Correspondence to:
    M Vis
    Department of Rheumatology, 4A 42, VU University Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands;m.vis{at}vumc.nl
View Full Text

Citation

Vis M, Havaardsholm EA, Haugeberg G, et al
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

Publication history

  • Accepted February 12, 2006
  • First published April 10, 2006.
Online issue publication 
October 12, 2006

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.